| Financial Year |
March 31 2023 |
| Monetary Funds |
4,617,107,168.09 |
| Held-for-trading Financial Assets |
200,000,000.00 |
| Notes Receivable |
2,490,368.23 |
| Accounts Receivable |
1,320,671,613.52 |
| Advances to Suppliers |
36,988,951.36 |
| Other Receivables |
113,294,865.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,031,477,983.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
192,265,463.83 |
| Total Current Assets |
7,762,006,986.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,824,251.03 |
| Long-term Equity Investment |
484,243,305.86 |
| Investment Properties |
84,054,976.80 |
| Fixed Assetes |
3,403,394,875.28 |
| Under-construction Projects |
852,714,854.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
442,441,524.64 |
| R&D expenses |
66,239,438.32 |
| Goodwill |
9,144,977.42 |
| Long-Term Deferred and Prepaid Expenses |
6,364,869.90 |
| Deferred Income Tax Assets |
28,003,660.52 |
| Other Non-Current Assets |
566,654,422.23 |
| Sub-Total of Non-Current Assets |
6,419,896,758.84 |
| Total Assets |
14,181,903,744.85 |
| Short-Term Loans |
2,925,073,534.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
147,455,406.24 |
| Accounts Payable |
355,925,131.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,464,236.40 |
| Taxes Payable |
56,302,653.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
134,075,322.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
456,077,829.24 |
| Other Current Liabilities |
49,876,375.48 |
| Sub-Total of Current Liabilities |
4,180,661,451.57 |
| Long-term Loans |
1,797,364,304.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
249,545,754.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,584,215.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,151,640,422.49 |
| Total Liabilities |
6,332,301,874.06 |
| Paid-In Capital(Or Share Stock) |
1,746,472,532.00 |
| Capital Surplus |
3,889,229,791.60 |
| Surplus Reserve |
123,179,779.30 |
| LESS:Treasury Stock |
100,000,765.86 |
| Undistributed Profits |
748,892,176.76 |
| Minority Stockholder's Interest |
1,488,880,449.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,360,721,420.87 |
| Owner's Equity（Stockholder's Equity） |
7,849,601,870.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,181,903,744.85 |
